Objectives-To assess race-specific incidence and prevalence rates for systemic lupus erythematosus (SLE) using 1991 National Census data and to ascertain the frequency of clinical/laboratory features of a geographically complete cohort of patients with SLE. Methods-Multiple methods of retrieval were used to ascertain SLE patients including screening request cards for immunology investigations. Patients were classified according to the revised ARA criteria. Multiple logistic regression analysis was used to study the effects of age at diagnosis on the frequency of clinical/laboratory SLE features. Results-The overall one year period prevalence rate for SLE was 24-7 (age adjusted, 95% CI: 20.7-28.8)/100 000. Highest rates were seen in Afro-Caribbeans (207 (111-302)/100 000), followed by 
mean age at diagnosis of SLE was 40-9 years (range: 11-83) with a mean interval between first definite SLE symptom and diagnosis of 61 months (0-518). In 85% of patients the first definite lupus feature was musculoskeletal and/or cutaneous. In this SLE cohort renal disease (22%) was observed less commonly than in previous studies and the 'classic' butterfly rash was present in only 30% ofpatients. Malar rash, thrombocytopaenia, positive anti-dsDNA antibodies, hypocomplementaemia (C4), and positive IgG anticardiolipin antibodies were all seen less commonly with increasing age at diagnosis. Conclusions-A closer estimate of the true frequency of clinical/laboratory SLE manifestations is likely from this geographically complete cohort of patients compared with studies that may be skewed by referral patterns. (Ann Rheum Dis 1994; 53: 675-680) Previously published data concerning the epidemiology of systemic lupus erythematosus (SLE) Nottinghamshire."4 This is calculated from indicators of low income, unemployment, lack of skills, poor housing, poor health and family/educational problems. There are four levels of disadvantage, below average, moderate, serious, and extreme. 3) Residence status for each patient was assessed (that is, whether or not they owned their home, were a council tenant, or rented accommodation from a landlord).
LABORATORY METHODS
Anti-nuclear antibodies Sera were screened at a 1: 10 dilution on a rat liver substrate by indirect immunofluorescence using polyvalent anti-human Ig. Positive sera were then titred using monovalent anti-sera to IgG and IgM.
Anti-dsDNA antibodies Two methods were used which involved: a) Crithidia lucilliae substrate by an indirect immunofluorescence; and b) an ELISA procedure (Diamedix Corporation, Florida).
Antibodies to extractable nuclear antigens These were identified by counter-current electrophoresis using rabbit thymus extract and human spleen extract on agarose gel, antibodies were specified using appropriate reference sera characterised from CDC standards (Centres for Disease Control, Atlanta, USA).
Rheumatoid factor Using the Rose-Waaler assay, with a titre -1:16 considered positive. Plasma C3 degradation products (C3dg) This was performed using double-decker rocket immuno-electrophoresis through anti-C3c and anti-C3d (Dako).
Anti-Cardiolipin antibodies These were identified by an ELISA method as described by Gharavi et al,5 and validated against international workshop standards obtained from the Rayne Institute, St Thomas's Hospital, London.
Lupus anticoagulant Detected by measuring the effect of patients' plasma on the kaolin clotting time of normnal plasma. '6 Plasma C3 and C4 complement levels Assayed by fluid phase turbidimetry.
STATISTICS
All data were stored on a mainframe computer and analyses were performed using SPSS-X3 Anti-RNP 22 19 24 Anti-Ro being significant, which differ from the conventional values in the ARA criteria. A higher frequency of Raynaud's phenomenon in this study was also observed. Only 54% of SLE patients had anti-dsDNA antibodies by Crithidia lucilliae and/or ELISA, and anti-Sm antibodies were infrequent (3%).
THE EFFECT OF INCREASING AGE AT DIAGNOSIS ON THE FREQUENCY OF CLINICAL AND LABORATORY MANIFESTATIONS
Adjusted odds ratios (OR) and 95% confidence intervals (CI) for the association or selected manifestations and age is shown in The frequency of antibodies to dsDNA (54%, using a Crithidia Lucilliae and ELISA assay) accords well with other studies.5 6 Several patients had negative results using a Crithidia assay, but positive using a commercially available dsDNA ELISA assay confirming the reduced sensitivity of the Crithidia Lucilliae assay. This is likely to contribute to the lower frequency of antidsDNA antibodies (28%) in some previous studies in which these antibodies were detected only by the Crithidia assay.23
In Nottingham, the highest incidence of SLE is seen in the 40-59 year age group' and malar rash, thrombocytopaenia, hypocomplementaemia (C4), antibodies to dsDNA, and IgG anti-cardiolipin antibodies have been shown to be less common with increasing age at diagnosis. No relationship with frequency of renal disease was identified but this may be because of the low total number of SLE patients with proteinuria. Multivariate logistic regression analysis permits control of potential confounding factors allowing age at diagnosis to be a continuous variable, rather than forming arbitrary division. The manifestations that vary with age at diagnosis accord well with the findings ofWard and Studenski,2' who used a similar analytical approach. Our study did not specifically address severity of disease but a relationship between antibodies to dsDNA and hypocomplementaemia with clinical exacerbations in SLE is well established. 25 26 It is therefore reasonable to imply that SLE presenting at an older age may be a milder disease contrasting with the sick young SLE patient with a butterfly rash.
In summary, this is the first study in the UK to present frequencies of SLE clinical manifestations in a complete cohort of patients living in a geographically defined area. Serious manifestations of SLE such as renal disease and particularly seizures and psychosis are not common.
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Addendum
There was en error in our previous publication.' Table 5 
